Company: RGNT
Filing Date: 2025-02-12
Form Type: DRS/A
Source: 0001213900-25-012299
Chunk: 309

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-02-12
Form: DRS/A
Chunk 309
---
| + | Indicates a management contract or any compensatory plan, contract or arrangement. |

<div align='center'>II-8

SIGNATURES</div>

Pursuant to the requirements
of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form F-1 and has duly caused this Registration Statement to be signed on its behalf by the undersigned,
thereunto duly authorized, in Herzliya, Israel on this day of , 2025.

| REGENTIS BIOMATERIALS LTD. |                         |
| By:                        |                         |
|                            | Dr. Eli Hazum,          |
|                            | Chief Executive Officer |

Pursuant to the requirements
of the Securities Act, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

| Signature         |     | Title                                        |     | Date |
|                   |     | Chief Executive Officer                      |     |      |
| Dr. Eli Hazum     |     | -Principal Executive Officer                 |     |      |
|                   |     | Chief Financial Officer                      |     |      |
| Arie Gordashnikov |     | -Principal Financial and Accounting Officer  |     |      |
| ‌                 |     | Director, Chairman of the Board of Directors |     |      |
| Dr. Ehud Geller   |     |                                              |     |      |
| ‌                 |     | Director                                     |     |      |
| Jeff Dykan        |     |                                              |     |      |
| ‌                 |     | Director                                     |     |      |
| Keith Valentine   |     |                                              |     |      |

<div align='center'>II-9

SIGNATURE OF AUTHORIZED REPRESENTATIVE IN THE UNITED STATES</div>

Pursuant to the requirements
of the Securities Act of 1933, as amended, the undersigned, Puglisi & Associates, the duly authorized representative in the United
States of Regentis Biomaterials Ltd., has signed this Registration Statement on this day of , 2025.

| Puglisi & Associates           |                   |
| Authorized U.S. Representative |                   |
| Name:                          | Donald J. Puglisi |
| Title:                         | Managing Director |

<div align='center'>II-10</div>